Global Health · NSE: MEDANTA · BSE: 543654
Q4 FY25 results · Jan–Mar 2025
Global Health reported revenue from operations of ₹931.25 crore (up 15.2% from Q4 FY24) and net profit of ₹101.38 crore (down 20.4% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 931.25 | 808.63 | +15.2% | 943.44 | −1.3% |
| Other income | 22.93 | 27.42 | −16.4% | 16.02 | +43.1% |
| Total income | 954.18 | 836.05 | +14.1% | 959.46 | −0.6% |
| Profit before tax | 133.44 | 143.09 | −6.7% | 189.07 | −29.4% |
| Net profit for the period | 101.38 | 127.35 | −20.4% | 142.86 | −29.0% |
| Attributable to shareholders of the company | 101.40 | 127.38 | −20.4% | 142.91 | −29.0% |
| EPS, basic (₹) | 3.77 | 4.74 | −20.5% | 5.32 | −29.1% |
| Net margin (%) | 10.9 | 15.7 | 15.1 |
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 802.87 | 578.64 | +38.7% | 624.40 | +28.6% |
| Other income | 25.67 | 32.55 | −21.1% | 22.17 | +15.8% |
| Total income | 828.53 | 611.19 | +35.6% | 646.57 | +28.1% |
| Profit before tax | 125.89 | 125.17 | +0.6% | 132.31 | −4.9% |
| Net profit for the period | 93.41 | 92.24 | +1.3% | 99.31 | −5.9% |
| EPS, basic (₹) | 3.48 | 3.43 | +1.5% | 3.70 | −5.9% |
| Net margin (%) | 11.6 | 15.9 | 15.9 |
Consolidated
- Filed with BSE
- 15 May 2025, 17:04 IST
- Board meeting
- 15 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 15 May 2025, 17:04 IST
- Board meeting
- 15 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE